Drugs / LAIV H7N3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01511419 | Apr → Jun 2012 | avian influenza | PATH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAIV H7N3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01511419 ↗ |
| Modality | Vaccine | “Safety Trial of Live Attenuated Influenza (H7N3) Vaccine” NCT01511419 ↗ |
| Route | Intranasal | “Route of administration: Intranasal aerosol.” NCT01511419 ↗ |